Contribution: Industrial Research Assistance Program – Contributions to Firms
VVecteur Bio Inc.
$320,600.00
UKRI Biomanufacturing - 10101911 Novel VVP Platform - Next generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics
EF 2024-25 · 2024-06-03
Résumé
This project focuses on increasing viral vector productivity at least 50-100 folds higher by the genetic modification of the 293-cell line targeting genes with crucial role in viral vector production and quality. It is being carried under the IRAP International Program: Canada-UK Biomanufacturing in collaboration with UK partners HexagonFab and Revvity.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Beaconsfield|Beaconsfield, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
724228879
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2026-06-05
Agreement Number
1019854
Agreement Start Date
2024-06-03
Agreement Title
UKRI Biomanufacturing - 10101911 Novel VVP Platform - Next generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics
Agreement Title (French)
UKRI Biomanufacturing — 10101911 Novel VVP Platform — Plateforme de production à haut rendement de nouvelle génération pour les vecteurs viraux de thérapie cellulaire et génique et d’autres produits biologiques complexes
Agreement Type
Contribution
Agreement Value
$320,600.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project focuses on increasing viral vector productivity at least 50-100 folds higher by the genetic modification of the 293-cell line targeting genes with crucial role in viral vector production and quality. It is being carried under the IRAP International Program: Canada-UK Biomanufacturing in collaboration with UK partners HexagonFab and Revvity.
Description (French)
Ce projet vise à augmenter la productivité des vecteurs viraux d’au moins 50 à 100 fois par la modification génétique de la lignée de cellules 293 en ciblant les gènes qui jouent un rôle crucial dans la production et la qualité des vecteurs viraux. Il est réalisé dans le cadre du programme international du PARI : Canada-RU Biofabrication, en collaboration avec les partenaires britanniques HexagonFab et Revvity.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Lac-Saint-Louis
Federal Riding (French)
Lac-Saint-Louis
Federal Riding Number
24036
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
724228879
Recipient City
Beaconsfield|Beaconsfield
Recipient Country
CA
Recipient Legal Name
VVecteur Bio Inc.
Recipient Operating Name
Vvector Bio Inc
Recipient Postal Code
H9W 6C9
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2024-2025-Q2-1019854
